메뉴 건너뛰기




Volumn 67, Issue SUPPL. 1, 2005, Pages

Cost-effectiveness of type 2 diabetes screening: Results from recently published studies

Author keywords

Cost effectiveness analyses; Screening strategies for undetected type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C;

EID: 23844542697     PISSN: 09413790     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858232     Document Type: Review
Times cited : (21)

References (33)
  • 1
    • 0029149309 scopus 로고
    • Prevalence and determinants of glucose intolerance in a Dutch caucasian population. The Hoorn Study
    • Mooy JM, Grootenhuis PA, de Vries H et al. Prevalence and determinants of glucose intolerance in a Dutch caucasian population. The Hoorn Study. Diabetes Care 1995; 18: 1270-1273
    • (1995) Diabetes Care , vol.18 , pp. 1270-1273
    • Mooy, J.M.1    Grootenhuis, P.A.2    De Vries, H.3
  • 2
    • 0032497083 scopus 로고    scopus 로고
    • Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Re-analysis of European epidemiological data
    • DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Re-analysis of European epidemiological data. BMJ 1998; 317: 371-375
    • (1998) BMJ , vol.317 , pp. 371-375
  • 3
    • 0037300945 scopus 로고    scopus 로고
    • High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA Survey 2000
    • Rathmann W, Haastert B, Icks A et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA Survey 2000. Diabetologia 2003; 46: 182-189
    • (2003) Diabetologia , vol.46 , pp. 182-189
    • Rathmann, W.1    Haastert, B.2    Icks, A.3
  • 4
    • 0033808127 scopus 로고    scopus 로고
    • The Addition Study proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening
    • Lauritzen T, Griffin S, Borch-Johnsen K et al. The Addition Study proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. Int J Obesity 2000; 24: S6-S11
    • (2000) Int J Obesity , vol.24
    • Lauritzen, T.1    Griffin, S.2    Borch-Johnsen, K.3
  • 5
    • 0035926055 scopus 로고    scopus 로고
    • Should we screen for type 2 diabetes? Evaluation against National Screening Committee Criteria
    • Wareham N, Griffin SJ. Should we screen for type 2 diabetes? Evaluation against National Screening Committee Criteria. BMJ 2001; 322: 986-988
    • (2001) BMJ , vol.322 , pp. 986-988
    • Wareham, N.1    Griffin, S.J.2
  • 6
    • 0037490987 scopus 로고    scopus 로고
    • Undiagnosed diabetes must be detected
    • Streets P. Undiagnosed diabetes must be detected. BMJ 2001; 323: 453-454
    • (2001) BMJ , vol.323 , pp. 453-454
    • Streets, P.1
  • 8
    • 1842334456 scopus 로고    scopus 로고
    • Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
    • The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197
    • (1997) Diabetes Care , vol.20 , pp. 1183-1197
  • 10
    • 0037890021 scopus 로고    scopus 로고
    • Macrovascular risk and diagnostic criteria for type 2 diabetes
    • Jesudason DR, Dunstan K, Leong D et al. Macrovascular risk and diagnostic criteria for type 2 diabetes. Diabetes Care 2003; 26: 485-490
    • (2003) Diabetes Care , vol.26 , pp. 485-490
    • Jesudason, D.R.1    Dunstan, K.2    Leong, D.3
  • 11
    • 0037833498 scopus 로고    scopus 로고
    • The economics of screening and treatment in type 2 diabetes mellitus
    • Raikou M, McGuire A. The economics of screening and treatment in type 2 diabetes mellitus. Pharmacoeconomics 2003; 8: 543-564
    • (2003) Pharmacoeconomics , vol.8 , pp. 543-564
    • Raikou, M.1    McGuire, A.2
  • 12
    • 0032567110 scopus 로고    scopus 로고
    • The cost-effectiveness of screening for type 2 diabetes
    • Engelgau M, Venkat Narayan K, Thomson T et al. The cost-effectiveness of screening for type 2 diabetes. JAMA 1998; 280: 1757-1763
    • (1998) JAMA , vol.280 , pp. 1757-1763
    • Engelgau, M.1    Venkat Narayan, K.2    Thomson, T.3
  • 14
    • 0034807886 scopus 로고    scopus 로고
    • A computer simulation model for cost-effectiveness analysis of mass screening for type 2 diabetes mellitus
    • Chen THH, Yen MF, Tung TH. A computer simulation model for cost-effectiveness analysis of mass screening for type 2 diabetes mellitus. Diabetes Research and Clinical Practice 2001; 54 (1): S37-S42
    • (2001) Diabetes Research and Clinical Practice , vol.54 , Issue.1
    • Chen, T.H.H.1    Yen, M.F.2    Tung, T.H.3
  • 15
    • 0033913885 scopus 로고    scopus 로고
    • A cost analysis of community screening for diabetes in the Central Wisconsin Medicare population
    • Lee DS, Remington P, Madagame J et al. A cost analysis of community screening for diabetes in the Central Wisconsin Medicare population. Wisconsin Medical Journal 2000; 99: 39-44
    • (2000) Wisconsin Medical Journal , vol.99 , pp. 39-44
    • Lee, D.S.1    Remington, P.2    Madagame, J.3
  • 16
    • 0032867226 scopus 로고    scopus 로고
    • Economic evaluation of alternative indicators for screening for diabetes mellitus
    • Shirasaya K, Miyakawa M, Yoshida K et al. Economic evaluation of alternative indicators for screening for diabetes mellitus. Preventive Medicine 1999; 29: 79-86
    • (1999) Preventive Medicine , vol.29 , pp. 79-86
    • Shirasaya, K.1    Miyakawa, M.2    Yoshida, K.3
  • 17
    • 0041823256 scopus 로고    scopus 로고
    • Cost of screening for pre-diabetes among US adults
    • Zhang P, Engelgau M, Valdez R et al. Cost of screening for pre-diabetes among US adults. Diabetes Care 2003; 26: 2536-2542
    • (2003) Diabetes Care , vol.26 , pp. 2536-2542
    • Zhang, P.1    Engelgau, M.2    Valdez, R.3
  • 18
    • 4444296990 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of different screening procedures for type 2 diabetes: The KORA Survey 2000
    • Icks A, Haastert B, Gandjour A et al. Cost-effectiveness analysis of different screening procedures for type 2 diabetes: The KORA Survey 2000. Diabetes Care 2004; 27: 2120-2128
    • (2004) Diabetes Care , vol.27 , pp. 2120-2128
    • Icks, A.1    Haastert, B.2    Gandjour, A.3
  • 22
    • 0035828452 scopus 로고    scopus 로고
    • Screening for diabetes in general practice: Cross sectional population study
    • Lawrence JM, Bennett P, Young A et al. Screening for diabetes in general practice: cross sectional population study. BMJ 2001; 323: 548-551
    • (2001) BMJ , vol.323 , pp. 548-551
    • Lawrence, J.M.1    Bennett, P.2    Young, A.3
  • 23
    • 23844537437 scopus 로고    scopus 로고
    • The MONICA Augsburg surveys-basis for prospective cohort studies
    • Löwel H, Döring A, Schneider A et al. The MONICA Augsburg surveys-basis for prospective cohort studies. Gesundheitswesen 2005; 67 S1: S13-S18
    • (2005) Gesundheitswesen , vol.67 S1
    • Löwel, H.1    Döring, A.2    Schneider, A.3
  • 24
    • 23844467739 scopus 로고    scopus 로고
    • KORA - A research platform for population based health research
    • Holle R, Happich M, Löwel H et al. KORA - A research platform for population based health research. Gesundheitswesen 2005; 67 S1: S19-S25
    • (2005) Gesundheitswesen , vol.67 S1
    • Holle, R.1    Happich, M.2    Löwel, H.3
  • 25
    • 23844472247 scopus 로고    scopus 로고
    • KORA-gen - Resource for population genetics, controls and a broad spectrum of disease phenotypes
    • Wichmann HE, Gieger C, Illig T et al. KORA-gen - Resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 2005; 67S1: S26-S30
    • (2005) Gesundheitswesen , vol.67 S1
    • Wichmann, H.E.1    Gieger, C.2    Illig, T.3
  • 26
    • 23844525382 scopus 로고    scopus 로고
    • The population-based Acute Myocardial Infarction (AMI) Registry of the MONICA/KORA study region of Augsburg
    • Löwel H, Meisinger C, Heier M et al. The population-based Acute Myocardial Infarction (AMI) Registry of the MONICA/KORA study region of Augsburg. Gesundheitswesen 2005; 67 S1: S31-S37
    • (2005) Gesundheitswesen , vol.67 S1
    • Löwel, H.1    Meisinger, C.2    Heier, M.3
  • 27
    • 23844545833 scopus 로고    scopus 로고
    • Fall-Kohorten-Studien: Ein effektives design zur untersuchung von biomarkern als risikofaktoren für chronische krankheiten - Darstellung am beispiel der MONICA/ KORA augsburg fall-kohorten studie 1984-2002
    • Thorand B, Schneider A, Baumert J et al. Fall-Kohorten-Studien: Ein effektives Design zur Untersuchung von Biomarkern als Risikofaktoren für chronische Krankheiten - Darstellung am Beispiel der MONICA/ KORA Augsburg Fall-Kohorten Studie 1984-2002. Gesundheitswesen 2005; 67 S1: S98-S102
    • (2005) Gesundheitswesen , vol.67 S1
    • Thorand, B.1    Schneider, A.2    Baumert, J.3
  • 28
    • 23844464069 scopus 로고    scopus 로고
    • Type 2 Diabetes mellitus in Augsburg - An epidemiological overview
    • Meisinger C, Döring A, Heier M et al. Type 2 Diabetes mellitus in Augsburg - an epidemiological overview. Gesundheitswesen 2005; 67 S1: S103-S109
    • (2005) Gesundheitswesen , vol.67 S1
    • Meisinger, C.1    Döring, A.2    Heier, M.3
  • 29
    • 23844433580 scopus 로고    scopus 로고
    • The diabetes epidemic in the elderly population in western Europe: Data from population-based studies
    • Rathmann W, Haastert B, Icks A et al. The Diabetes Epidemic in the Elderly Population in Western Europe: Data from Population-Based Studies. Gesundheitswesen 2005; 67 S1: S110-S114
    • (2005) Gesundheitswesen , vol.67 S1
    • Rathmann, W.1    Haastert, B.2    Icks, A.3
  • 30
    • 23844449338 scopus 로고    scopus 로고
    • Inflammation and type 2 diabetes: Results from KORA Augsburg
    • Herder C, Illig T, Rathmann W et al. Inflammation and Type 2 Diabetes: Results from KORA Augsburg. Gesundheitswesen 2005; 67 S1: S115-S121
    • (2005) Gesundheitswesen , vol.67 S1
    • Herder, C.1    Illig, T.2    Rathmann, W.3
  • 31
    • 23844537435 scopus 로고    scopus 로고
    • Genetics of type 2 diabetes: Impact of interleukin-6 gene variants
    • Illig T, Bongardt F, Schöpfer-Wendels A et al. Genetics of Type 2 Diabetes: Impact of Interleukin-6 Gene Variants. Gesundheitswesen 2005; 67 S1: S122-S126
    • (2005) Gesundheitswesen , vol.67 S1
    • Illig, T.1    Bongardt, F.2    Schöpfer-Wendels, A.3
  • 32
    • 23844506452 scopus 로고    scopus 로고
    • Health inequalities among persons with type 2 diabetes: The example of intermittent claudication
    • Mielck A, Reisig V, Rathmann W et al. Health inequalities among persons with type 2 diabetes: The example of intermittent claudication. Gesundheitswesen 2005; 67 S1: S137-S143
    • (2005) Gesundheitswesen , vol.67 S1
    • Mielck, A.1    Reisig, V.2    Rathmann, W.3
  • 33
    • 23844490081 scopus 로고    scopus 로고
    • Disease Management Programme in Deutschland: Erste Reaktionen der Diabetiker
    • Eller M, Satzinger W, Holle R et al. Disease Management Programme in Deutschland: Erste Reaktionen der Diabetiker. Gesundheitswesen 2005; 67 S1: S144-S149
    • (2005) Gesundheitswesen , vol.67 S1
    • Eller, M.1    Satzinger, W.2    Holle, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.